Overview

Mild cognitive impairment (MCI) is the stage between the expected cognitive decline of normal aging and the more serious decline of dementia. It can involve problems with memory, language, thinking and judgment that are greater than normal age-related changes.

If you have mild cognitive impairment, you may be aware that your memory or mental function has "slipped." Your family and close friends also may notice a change. But these changes aren't severe enough to significantly interfere with your daily life and usual activities.

Mild cognitive impairment may increase your risk of later developing dementia caused by Alzheimer's disease or other neurological conditions. But some people with mild cognitive impairment never get worse, and a few eventually get better.

Mild cognitive impairment care at Mayo Clinic

Symptoms

Your brain, like the rest of your body, changes as you grow older. Many people notice gradually increasing forgetfulness as they age. It may take longer to think of a word or to recall a person's name.

But consistent or increasing concern about your mental performance may suggest mild cognitive impairment (MCI). Cognitive issues may go beyond what's expected and indicate possible MCI if you experience any or all of the following:

  • You forget things more often.
  • You forget important events such as appointments or social engagements.
  • You lose your train of thought or the thread of conversations, books or movies.
  • You feel increasingly overwhelmed by making decisions, planning steps to accomplish a task or understanding instructions.
  • You start to have trouble finding your way around familiar environments.
  • You become more impulsive or show increasingly poor judgment.
  • Your family and friends notice any of these changes.

If you have MCI, you may also experience:

  • Depression
  • Irritability and aggression
  • Anxiety
  • Apathy

Causes

There's no single cause of mild cognitive impairment (MCI), just as there's no single outcome for the disorder. Symptoms of MCI may remain stable for years, progress to Alzheimer's disease or another type of dementia, or improve over time.

Current evidence indicates that MCI often, but not always, develops from a lesser degree of the same types of brain changes seen in Alzheimer's disease or other forms of dementia. Some of these changes have been identified in autopsy studies of people with MCI. These changes include:

  • Abnormal clumps of beta-amyloid protein (plaques) and microscopic protein clumps of tau characteristic of Alzheimer's disease (tangles)
  • Lewy bodies, which are microscopic clumps of another protein associated with Parkinson's disease, dementia with Lewy bodies and some cases of Alzheimer's disease
  • Small strokes or reduced blood flow through brain blood vessels

Brain-imaging studies show that the following changes may be associated with MCI:

  • Shrinkage of the hippocampus, a brain region important for memory
  • Enlargement of the brain's fluid-filled spaces (ventricles)
  • Reduced use of glucose, the sugar that's the primary source of energy for cells, in key brain regions

Risk factors

The strongest risk factors for MCI are:

  • Increasing age
  • Having a specific form of a gene known as APOE-e4, also linked to Alzheimer's disease — though having the gene doesn't guarantee that you'll experience cognitive decline

Other medical conditions and lifestyle factors have been linked to an increased risk of cognitive change, including:

  • Diabetes
  • Smoking
  • High blood pressure
  • Elevated cholesterol
  • Obesity
  • Depression
  • Lack of physical exercise
  • Low education level
  • Infrequent participation in mentally or socially stimulating activities

Complications

People with MCI have a significantly increased risk — but not a certainty — of developing dementia. Overall, about 1 to 3 percent of older adults develop dementia every year. Studies suggest that around 10 to 15 percent of individuals with MCI go on to develop dementia each year.

Mild cognitive impairment (MCI) care at Mayo Clinic

Aug. 23, 2018
References
  1. McDade EM, et al. Mild cognitive impairment: Epidemiology, pathology, and clinical assessment. https://www.uptodate.com/contents/search. Accessed Aug. 6, 2018.
  2. Daroff RB, et al. Alzheimer disease and other dementias. In: Bradley's Neurology in Clinical Practice. 7th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. https://www.clinicalkey.com. Accessed Aug. 6, 2018.
  3. Knopman DS, et al. Mild cognitive impairment and mild dementia: A clinical perspective. Mayo Clinic Proceedings. 2014;89:1452.
  4. Albert MS, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's and Dementia. 2011;7:270.
  5. Mild cognitive impairment (MCI). Alzheimer's Association. https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/mild-cognitive-impairment. Accessed Aug. 6, 2018.
  6. Forrester SN, et al. Patterns of neuropsychiatric symptoms in MCI and risk of dementia. American Journal of Geriatric Psychiatry. 2016;24:117.
  7. McDade EM, et al. Mild cognitive impairment: Prognosis and treatment. https://www.uptodate.com/contents/search. Accessed Aug. 6, 2018.
  8. Ferri FF. Mild cognitive impairment. In: Ferri's Clinical Advisor 2019. Philadelphia, Pa.: Elsevier; 2019. https://www.clinicalkey.com. Accessed Aug. 6, 2018.
  9. Petersen RC, et al. Practice guideline update summary: Mild cognitive impairment. Neurology. 2018;90:1.
  10. Riggin ER. Allscripts EPSi. Mayo Clinic, Rochester, Minn. March 27, 2018.
  11. Graff-Radford J. (expert opinion). Mayo Clinic, Rochester, Minn. Aug. 7, 2018.